Farrukh Usman
Chief Executive Officer (CEO)
Farrukh Usman is the founder and CEO of Byonyks, a medical device company established in 2019 focused on advancing dialysis technology. He led the team that obtained FDA clearance for the Byonyks X-1 Automated Peritoneal Dialysis (APD) Cycler, making Byonyks only the third company in the world to receive this clearance.
A graduate of Harvard University, Farrukh has been involved in the design and development of multiple dialysis systems, including home hemodialysis and other automated peritoneal dialysis machines. His work has contributed to the development of more than half of the APD machines currently marketed in the United States.
He has also played a role in early-stage projects involving the artificial pancreas and closed-loop insulin delivery systems, in collaboration with companies such as Insulet, Dexcom, and Abbott. His background includes experience in surgical robotics and other medical technologies.
At Byonyks, Farrukh oversees research and product development in both Chicago and Lahore, with a focus on creating bloodless and acid-free dialysis systems. The company has submitted multiple patent applications and continues to work on expanding access to advanced renal care.
